Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cooper

Showing results (191-200 of 319) with videos related to

Pageof 32
Sort By:
Journal of Hazardous Materials|November 27, 2022
Biodegradation potential of residue generated during the in-situ burning of oil in the marine environmentRuby Pyke, Nathalie Fortin, Jessica Wasserscheid, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 13, 2016
Brief Report: Enhanced Normalization of CD4/CD8 Ratio With Earlier Antiretroviral Therapy at Primary HIV InfectionJohn Thornhill, Jamie Inshaw, Pontiano Kaleebu, et al.
Vaccine|November 9, 2004
Interleukin-12 redirects murine immune responses to soluble or aluminum phosphate adsorbed HSV-2 glycoprotein D towards Th1 and CD4+ CTL responsesDavid Cooper, Michael W Pride, Min Guo, et al.
Cell Host & Microbe|March 4, 2022
Neutralization and durability of 2 or 3 doses of the BNT162b2 vaccine against Omicron SARS-CoV-2Hongjie Xia, Jing Zou, Chaitanya Kurhade, et al.
Plos One|November 9, 2013
Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapyWolfgang Stöhr, Sarah Fidler, Myra McClure, et al.
Biorxiv : the Preprint Server for Biology|January 14, 2021
Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited seraXuping Xie, Jing Zou, Camila R Fontes-Garfias, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2012
A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspirationXavier M Keutgen, Filippo Filicori, Michael J Crowley, et al.
Pilot and Feasibility Studies|April 1, 2026
A co-created randomised controlled feasibility trial of a peer-led complex oral health intervention in UK secondary schools: the RAISED In Yorkshire RiY study protocolYasmen Elsadek, Aruche-A-Noor Hamid, Poonam Anand, et al.
BMC Veterinary Research|July 1, 2020
The VetMAX™ M. tuberculosis complex PCR kit detects MTBC DNA in antemortem and postmortem samples from white rhinoceros (Ceratotherium simum), African elephants (Loxodonta africana) and African buffaloes (Syncerus caffer)Wynand J Goosen, Tanya J Kerr, Léanie Kleynhans, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 29, 2013
A randomized phase 3 study comparing once-daily elvitegravir with twice-daily raltegravir in treatment-experienced subjects with HIV-1 infection: 96-week resultsRichard Elion, Jean-Michel Molina, José Ramón Arribas López, et al.
Pageof 32

Showing results (191-200 of 319) with videos related to

Sort By:
Pageof 32
Journal of Hazardous Materials|November 27, 2022
Biodegradation potential of residue generated during the in-situ burning of oil in the marine environmentRuby Pyke, Nathalie Fortin, Jessica Wasserscheid, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 13, 2016
Brief Report: Enhanced Normalization of CD4/CD8 Ratio With Earlier Antiretroviral Therapy at Primary HIV InfectionJohn Thornhill, Jamie Inshaw, Pontiano Kaleebu, et al.
Vaccine|November 9, 2004
Interleukin-12 redirects murine immune responses to soluble or aluminum phosphate adsorbed HSV-2 glycoprotein D towards Th1 and CD4+ CTL responsesDavid Cooper, Michael W Pride, Min Guo, et al.
Cell Host & Microbe|March 4, 2022
Neutralization and durability of 2 or 3 doses of the BNT162b2 vaccine against Omicron SARS-CoV-2Hongjie Xia, Jing Zou, Chaitanya Kurhade, et al.
Plos One|November 9, 2013
Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapyWolfgang Stöhr, Sarah Fidler, Myra McClure, et al.
Biorxiv : the Preprint Server for Biology|January 14, 2021
Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited seraXuping Xie, Jing Zou, Camila R Fontes-Garfias, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2012
A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspirationXavier M Keutgen, Filippo Filicori, Michael J Crowley, et al.
Pilot and Feasibility Studies|April 1, 2026
A co-created randomised controlled feasibility trial of a peer-led complex oral health intervention in UK secondary schools: the RAISED In Yorkshire RiY study protocolYasmen Elsadek, Aruche-A-Noor Hamid, Poonam Anand, et al.
BMC Veterinary Research|July 1, 2020
The VetMAX™ M. tuberculosis complex PCR kit detects MTBC DNA in antemortem and postmortem samples from white rhinoceros (Ceratotherium simum), African elephants (Loxodonta africana) and African buffaloes (Syncerus caffer)Wynand J Goosen, Tanya J Kerr, Léanie Kleynhans, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 29, 2013
A randomized phase 3 study comparing once-daily elvitegravir with twice-daily raltegravir in treatment-experienced subjects with HIV-1 infection: 96-week resultsRichard Elion, Jean-Michel Molina, José Ramón Arribas López, et al.
Pageof 32